NASDAQ$CLMT
Calumet Inc · Q1 2026 earnings
Q1 2026 earnings · · Investor relations
Briefing
Calumet reported Q1 2026 sales of $1.03B and a net loss of $317.0M on weak margins and derivatives.
Calumet's Q1 2026 sales were $1.03 billion with a gross loss of $87.5 million and net loss of $317.0 million versus $162.0 million a year ago. Specialty products and renewables segments face margin pressure; unrealized derivative loss $115.4M and interest $51.1M weighed on results.
- Sales $1.03B; net loss $(317.0)M.
- Gross loss $(87.5)M.
- Operating loss $(171.3)M.
- Derivative loss $115.4M.
- Montana Renewables segment strategic.
Headline financials
Revenue & EPS history
Calumet Specialty Products · Revenue · Quarterly
$1.03B
Forward guidance
RINs, SAF credits, and specialty product spreads discussed; tax attributes non-GAAP metrics used.
Tailwinds
- Large revenue base.
- Renewables tax credits potential.
- Adjusted EBITDA metrics tracked.
Headwinds
- Deep GAAP loss.
- Margin compression.
- High interest and hedge volatility.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 5 quarterly earnings reports · overlaid with Q1 2026
-4.3%
Avg return
Earnings day
-2.3%
Avg return
5 days after
+6.6%
Avg return
30 days after
17%
1 / 6 earnings
Positive
+6.5%
Q1 2025
Best reaction
-10.8%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -7.4% | -9.3% | +1.5% | |
| Q4 2025 | -10.8% | -3.0% | +6.1% | |
| Q3 2025 | -1.6% | -3.0% | -0.9% | |
| Q2 2025 | -3.6% | -4.2% | +19.7% | |
| Q1 2025 | +6.5% | +11.4% | +14.9% | |
| Q3 2024 | -8.6% | -6.0% | -1.9% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro